Astrazeneca (AZN) Total Assets (2006 - 2026)
Astrazeneca (AZN) total assets from Mar 31, 2006 to Mar 31, 2026. The current Astrazeneca (AZN) total assets is $114B. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Total Assets
Total Assets
Astrazeneca (AZN) Total Assets CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +8.44% |
| 3 Years TTM | +5.82% |
| 5 Years TTM | +12.22% |
| 10 Years TTM | +6.89% |
| All Time TTM | +7.45% |
Annual Total Assets change of Astrazeneca (AZN)
| Year | Total Assets | Change |
|---|---|---|
| 2025 | $114B | +9.65% |
| 2024 | $104B | +2.88% |
| 2023 | $101B | +4.80% |
| 2022 | $96B | -8.43% |
| 2021 | $105B | +57.90% |
| 2020 | $67B | +8.72% |
| 2019 | $61B | +1.20% |
| 2018 | $61B | -4.27% |
| 2017 | $63B | +1.32% |
| 2016 | $63B | +4.00% |
| 2015 | $60B | +2.61% |
| 2014 | $59B | +4.82% |
| 2013 | $56B | +4.42% |
| 2012 | $54B | +1.33% |
| 2011 | $53B | -5.87% |
| 2010 | $56B | +2.20% |
| 2009 | $55B | +16.98% |
| 2008 | $47B | -2.10% |
| 2007 | $48B | +60.22% |
| 2006 | $30B | N/A |
Comparison Astrazeneca (AZN) total assets with competitors
Astrazeneca (AZN) total assets is $114.02B.
| Ticker | Name | Total Assets | Upside |
|---|---|---|---|
| NVO | Novo Nordisk | $559.22B | +390.48% |
| PFE | Pfizer Inc | $207.62B | +82.10% |
| JNJ | Johnson & Johnson | $200.89B | +76.20% |
| ABBV | Abbvie Inc | $136.46B | +19.69% |
| MRK | Merck & Co Inc | $128.69B | +12.87% |
| SNY | Sanofi | $128.02B | +12.29% |
| NVS | Novartis AG | $118.53B | +3.96% |
| LLY | Lilly(Eli) & Company | $116.58B | +2.25% |
| AMGN | AMGEN Inc | $92.50B | -18.87% |
| BMY | Bristol-Myers Squibb Company | $86.48B | -24.15% |
| GSK | GSK Plc | $82.91B | -27.29% |
| GILD | Gilead Sciences Inc | $56.28B | -50.64% |
| BIIB | Biogen Inc | $29.48B | -74.14% |
| GRFS | Grifols SA | $20.10B | -82.37% |
| OGN | Organon & Company | $13.00B | -88.60% |
| AMRN | Amarin Corp | $645.76M | -99.43% |
| SCLX | Scilex Holding Company | $293.63M | -99.74% |
| MIRA | Mira Pharmaceuticals Inc | $9.46M | -99.99% |
| MDCX | MDCorp | $7.43M | -99.99% |
| MDCXW | Medicus Pharma Ltd warrant | $7.43M | -99.99% |
| NSRX | Nasus Pharma Ltd | $5.00M | -100.00% |